Abstract
Destructive growth and metastasis characterize malignant tumors. As a rule, death results from the consequences of the metastasis. Although only isolated aspects of the metastatic process have been studied, regularities have been identified that are valid for every tumor. For example, proliferating neoplastic cells reach the basal membrane, penetrate it, and make their way into the connective tissue, where they have access to blood and lymph vessels and are carried to other organ systems. After the tumor cells or emboli are caught in the capillary network or the sinusoids of bone marrow, extravasation and renewed proliferation ensues [1]. The processes regulating these events are largely unknown. Liotta et al. [2] referred to the discordance between the regulation of tumor growth and metastasis in breast cancer, which underscores the difficulties of predicting the course of the disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bertolini DR, Mundy GR (1989) Metastasis to bone in mammals. In: Gorelik EL (ed) Metastasis/Dissemination. Kluwer, Dordrecht, pp 72–82
Liotta LA, Steeg PS, Stetler-Stevenson WG (1991) Cancer metastases and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327–336
Dickson RB, Lippman ME (1992) Molecular determinants of growth, angiogenesis and metastases in breast cancer. Semin Oncol 19: 286–298
Graeff H, Jaenicke F, Schmitt M (1991) Klinische und prognostische Bedeutung tumorassoziierter Proteasen in der gynäkologischen Onkologie. Geburtshilfe Frauenheilkd 51: 90–99
Duffy MJ (1992) The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 10: 145–155
Weiss L, Gilbert HA (1981) Bone metastasis. Hall, Boston
Galasko CSB (1986) Skeletal metastases. Butterworth, London
Regato del JA (1977) Pathways of metastatic spread of malignant tumors. Semin Oncol 4: 33–38
Southby J, Kissin MW, Danks JA et al. (1990) Immunohistochemical localization of parathyroid hormone-related protein in breast cancer. Cancer Res 50: 7710–7716
Powell GJ, Southby J, Danks JA et al. (1991) Localization of parathyroid-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51: 3059–3061
Bundred NJ, Walker RA, Ratcliffe WA et al. (1992) Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer 28: 690–692
Orr FW, Millar-Book W, Singh G (1990) Chemotactic activity of bone and platelet derived TGF-beta for bone metastasizing rat Walker 256 carcinosarcoma cells. Invasion Metastasis 10: 241–252
Scher HI, Yagoda A (1987) Bone metastases: pathogenesis, treatment and rationale for use of resorption inhibitors. Am J Med 82 [Suppl 2A]: 6–28
Paget S (1889) The distribution of secondary growth in cancer of the breast. Lancet I: 571–573
Dearnaley DP, Sloane JP, Ormerod MG et al. (1981) Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer 44: 85–90
Dearnaley DP, Sloane JP, Imrie SF et al. (1983) Detection of isolated mammary carinoma cells in marrow of patients with primary breast cancer. J R Soc Med 76: 359–364
Diel IJ, Kaufmann,M, Krempien B et al. (1990) Immunocytochemical detection of tumor cells in bone marrow in patients with primary breast cancer. Br J Cancer 62 [Suppl XII]: 3
Diel IJ, Kaufmann M, Goerner R et al. (1992) Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 10: 1534–1539
Redding WH, Coombes RC, Monaghan P et al. (1983) Detection of micrometastases in patients with primary breast cancer. Lancet II: 1271–1274
Mansi JL, Berger U, Easton D et al. (1987) Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J 295: 1093–1096
Jamshidi K, Swaim FH, Raisz G (1980) A new trephine for closed bone marrow biopsy. Acta Haematol 64: 216
Swallow DM, Gendler S, Griffith B et al. (1987) The hypervariable gene locus, which codes for the tumor associated epithelial mucins, is located on chromosome 1 region 1 q 21–24. Am Hum Genet 51: 289–294
Gendler SJ, Taylor-Papadimitriou J, Duhig T et al. (1988) A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 263: 12820–12823
Gendler SJ, Lancaster CA, Taylor-Papadimitriou J et al. (1990) Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 265: 15286–15293
Bastert G, Eichler A, Kaul S (1987) Monoclonal antibodies against human breast cancer. In: Rygaard, Brünner (eds) Immunodeficient animals in biomedical research, Karger, Basel, pp 224–227
Kaul S, Windecker S, Bastert G (1989) TAG 12: Reinigung und Produktion von monoklonalen Zweitantikörpern. In: Kaufmann M, Jarasch ED, Bastert G (eds) Klinische Tumorimmunologie in der Gynäkologie. Zuckschwerdt, Munich, pp 34–46
Mayer M (1990) Biochemical and biological aspects of the plasminogen activator system. Clin Biochem 23: 197–211
Bachmann F (1987) Thrombosis and haemostasis. In: Verstraete M, Lijnen HR, Arnout J (eds) International Society on Thrombosis and Haemostasis, Leuven University Press, Leuven, pp 227–265
Schmitt M, Jänicke F, Graeff H (1990) Tumour-associated fibrinolysis: the prognostic relevance of plasminogen activators uPA and tPA in human breast cancer, Blood Coagul Fibrinolysis 1: 695–702
Kramer MD, Vettel U, Schmitt M et al. (1992) Monoclonal antibodies against plasminogen activators and plasminogen. Fibrinolysis 6 [Suppl 4]: 103–111
Rochefort H (1992) Biological and clinical significance of cathepsin D in breast cancer. Acta Oncol 31: 125–130
Westley BR, Rochefort H (1980) A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20: 353–362
Garcia M, Capony F, Rochefort H (1992) Cathepsin D and breast cancer metastasis: biological and clinical significance. In: Dogliotto L, Sapino A, Bussolati G (eds) Breast cancer: biological and clinical progress. Kluwer, Dordrecht, pp 243–253
Burtis WJ, Wu T, Bunch L et al. (1987) Identification of a novel 17000 dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem 262: 7151–7156
Moseley JM, Kubota M, Diefenbach-Jagger H et al. (1987) Parathyroid hormone–related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 84: 5048–5052
Thiede MA, Rodan GA (1988) Expression of a calcium mobilizing parathyroid hormone-like peptide in lacting mammary tissue. Science 242: 278–280
Nicolson GL (1988) Organ specifity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7: 143–188
Frassica FJ, Sim FH (1988) Pathogenesis and prognosis. In: Sim FH (ed) Diagnosis and management of metastatic bone disease. Raven, New York, pp 1–6
Ewing J (1928) Neoplastic diseases: a treatise on tumors. Saunders, Philadelphia
Millar-Book W, Orr FW, Singh G (1990) In vitro effect of bone- and platelet- derived transforming growth factor beta on growth of Walker 256 carcinosarcoma cells. Clin Metastasis 8: 503–510
Kanis JA, Gray RES, Urwin G et al. (1980) Physilogy of bone and metabolic approaches to the treatment of skeletal metastases. In: Paterson AUG, Lees AW (eds) Fundamental problems in breast cancer, Kluwer, Dordrecht, pp 303–322
O’Briant KCO, Shpall EJ, Houston LL et al. (1991) Elimination of clonogenic breast cancer cells from human bone marrow. Cancer, 68: 272–1278
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Diel, I.J., Costa, S.D., Kaufmann, M., Bastert, G. (1994). Detection and Characterization of Tumor Cells in Bone Marrow of Patients with Primary Breast Cancer. In: Diel, I.J., Kaufmann, M., Bastert, G. (eds) Metastatic Bone Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78596-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-78596-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-57356-2
Online ISBN: 978-3-642-78596-2
eBook Packages: Springer Book Archive